Cell and gene therapy, NexCAR19, for the treatment of r/r B-cell lymphomas and leukemia receives approval

Prof. Rahul Purwar and his group, Department of Biosciences and Bioengineering, Developed cell and gene therapy, NexCAR19 has received approval from CDSCO (Central Drugs Standard Control Organization), Govt of India, for the treatment of r/r B-cell lymphomas and leukemia.

Year